Mentioned On
Episode Mentions
How I Invest with David Weisburd · Apr 22, 2026
E353: Why Biotech Is Struggling in Today’s Market (and the Future of Healthcare)
“Portfolio company using AI and longitudinal patient data to optimize clinical trial design; brought Parkinson's asset to phase 3 with single-trial FDA approval.”
Biotech Drug Development EconomicsInflation Reduction Act Impact on Pharma PricingChina's Dominance in Drug Discovery
View Analysis